The AHA yesterday voiced support for the Opioid Treatment Access Act (H.R. 6279), bipartisan legislation that would take steps to facilitate patients’ access to methadone treatment for opioid use disorder. The bill would direct the Substance Abuse and Mental Health Services Administration to study the impact of certain flexibilities implemented during the COVID-19 public health emergency to enhance access to methadone treatment services and reduce stigma; allow patients to receive one-month supplies of methadone after two years of continuous treatment; permit pharmacies to dispense methadone; and codify regulations that allow opioid treatment programs to operate mobile medication components without separate registration.

Related News Articles

Headline
The Food and Drug Administration recently updated its health care provider fact sheet on bebtelovimab to note that the monoclonal antibody is not expected…
Headline
The Workgroup for Electronic Data Interchange advisory group yesterday urged Health and Human Services Secretary Xavier Becerra to work closely with standards…
Headline
The Centers for Disease Control and Prevention today released updated guidelines for clinicians prescribing opioids to outpatients for short- or long-term…
Perspective
After Election Day, lawmakers will return to Washington to consider many important issues, including funding the government, the annual must-pass defense bill…
Headline
At an AHA virtual policy briefing today for congressional staff, hospital and health system leaders urged Congress to prioritize actions to address the…
Headline
As Congress begins to focus on its year-end agenda, AHA today urged lawmakers to prioritize certain actions to help hospitals and health systems address rising…